文献速递药物不良反应与药物警戒抗栓抗凝管理

达托霉素致国际标准化比值假性延长一例

False prolongation of International Normalized Ratio associated with daptomycin.
PubMed 文献 · Am J Health Syst Pharm · 2018-01-01

本文报道一例病态肥胖的51岁男性患者,因胆石性胰腺炎和胆道梗阻住院,在接受达托霉素治疗期间出现持续的国际标准化比值(INR)升高,但血栓弹力图(TEG)显示全血凝血功能正常。停用达托霉素并换用利奈唑胺后INR恢复正常,提示达托霉素可能导致假性INR升高。

要点

  • 达托霉素可能导致假性INR升高,尤其在使用特定实验室试剂检测凝血酶原时间时。
  • 对于接受达托霉素治疗且INR升高的患者,应结合血栓弹力图等检查综合评估凝血状态。
  • 若怀疑达托霉素相关假性INR升高,可考虑换用其他抗菌药物并监测INR变化。

核心结论

  • 达托霉素治疗可能导致假性且显著的INR升高,血栓弹力图结果提示INR升高为药物-实验室相互作用所致,而非真实抗凝状态。

研究设计与样本

  • 病例报告:一名病态肥胖的51岁男性患者,因胆石性胰腺炎和胆道梗阻住院,住院期间发生脓毒症并接受达托霉素治疗。

主要发现

  • 患者在接受达托霉素治疗第8天时,尽管已停用华法林9天,INR仍为2.6;住院第21天血栓弹力图显示全血凝血功能正常。
  • 其他抗凝标志物恢复正常,但INR持续升高直至停用达托霉素。
  • 换用利奈唑胺后患者INR恢复正常。

临床怎么用

  • 临床药师应警惕达托霉素可能导致假性INR升高,尤其在无华法林暴露或其他抗凝证据时。
  • 对于接受达托霉素且INR升高的患者,建议使用血栓弹力图等全局凝血检测辅助判断真实凝血状态。
  • 怀疑达托霉素相关假性INR升高时,可考虑换用其他抗菌药物并监测INR是否恢复正常。

局限性

  • 本文为单例病例报告,因果关系不能确定。
  • 文中提及的特定实验室试剂此前未被报道与达托霉素假性INR升高相关,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Persistent elevation of prothrombin time (PT) and International Normalized Ratio (INR) values in a patient receiving daptomycin is reported. SUMMARY: A morbidly obese 51-year-old man was hospitalized for evaluation for surgical intervention for gallstone pancreatitis and biliary obstruction. Previously prescribed warfarin therapy was withheld due to suspected coagulopathy and an elevated INR (5.1), and warfarin reversal was initiated. After undergoing partial cholecystectomy on hospital day 6, the patient developed sepsis and was treated with i.v. meropenem and daptomycin for vancomycin-resistant Enterococcus infection. Warfarin therapy, which had been resumed after cholecystectomy, was again discontinued on hospital day 12. On the eighth day of daptomycin therapy, the INR remained elevated (2.6) even though the patient had no warfarin exposure for 9 days. On hospital day 21, thromboelastography (TEG) indicated normal whole blood coagulation. Other anticoagulation markers normalized, but the INR remained elevated until daptomycin was discontinued. Daptomycin has been shown to falsely prolong the INR when specific laboratory reagents are used for PT and INR testing, but the specific reagent used in this case has not been previously implicated. CONCLUSION: Daptomycin therapy appeared to cause a false and substantial INR elevation in a patient who had been receiving warfarin. Results of TEG suggested that the INR elevation was an artifact of a drug-laboratory interaction and did not represent an anticoagulated state. The patient's INR normalized after linezolid was substituted for daptomycin.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Smith SE, Rumbaugh KA. False prolongation of International Normalized Ratio associated with daptomycin. Am J Health Syst Pharm. 2018. PMID: 29472508. doi:10.2146/ajhp170098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。